Drug Name: Qalsody

Indications: To treat amyotrophic lateral sclerosis in adults who have a SOD1 gene mutation.

Active Ingredient: Tofersen

Company: Biogen MA Inc.

Approval Date: 4/25/2023

More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215887s000lbl.pdf

Leave a Reply

Your email address will not be published. Required fields are marked *